A note: as of 2026, Eli Lilly's LillyDirect program has expanded vial availability for self-pay patients
Food & Drug Administration show this GLP-1 receptor agonist when paired with diet and exercise, can help the average adult shed 15% of their body weight or ~35 lbs, but longer-term yields showed results of a weight loss of ~30%
During semaglutide therapy, your stomach lining is already experiencing altered acid production and increased sensitivity to mechanical and chemical triggers
Head-to-head clinical trial data (the SURMOUNT-5 trial) shows tirzepatide (Zepbound) produces marginally better average weight loss than semaglutide (Wegovy) at equivalent treatment durations
Most of these treatmentsincluding those accessed through TrimRxrely on refrigeration to stay stable
How many you need will depend on several factors, including your age, activity level, physical health, frequency of injections, and how well your body responds to the treatment